Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 16, 2017 |
Director
Trans History: 23
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,671 | -- | 37,142 |
Feb 16, 2017 |
Director
Trans History: 67
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,671 | -- | 36,193 |
Feb 16, 2017 |
Director
Trans History: 79
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,671 | -- | 35,709 |
Feb 16, 2017 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,671 | -- | 37,504 |
Feb 14, 2017 |
Director
Trans History: 67
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,058 | $32.06 | 12,332 |
Feb 13, 2017 |
Director, President & CEO
Trans History: 127
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 13,409 | $22.57 | 213,740 |
Feb 13, 2017 |
Director, President & CEO
Trans History: 127
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 13,409 | $31.51 | 200,331 |
Feb 13, 2017 |
Director, President & CEO
Trans History: 127
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 13,409 | -- | -- |
Feb 13, 2017 |
Director
Trans History: 67
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,105 | $25.84 | 31,495 |
Feb 13, 2017 |
Director
Trans History: 67
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 14,105 | $31.40 | 17,390 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.